September 28, 2018
Via Email and EDGAR
Jeffrey Gabor
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: Jaguar Health, Inc.
Registration Statement on Form S-1
Filed on September 12, 2018 and amended on September 28, 2018
File No. 333-227292
Ladies and Gentlemen:
Jaguar Health, Inc., a Delaware corporation (the “Registrant”), hereby requests the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) be declared effective by the Securities and Exchange Commission on Monday, October 1, 2018, at 5:00 p.m., Eastern Time, or as soon thereafter as is practicable.
Please confirm effectiveness by advising our counsel, Donald C. Reinke of Reed Smith LLP, at (650) 352-0532.
|
Very truly yours, |
|
|
|
|
|
Jaguar Health, Inc. |
|
|
|
|
|
|
|
|
/s/ Lisa A. Conte |
|
|
Lisa A. Conte |
|
|
Chief Executive Officer and President |
|
Jaguar Health, Inc. · 201 Mission Street, Suite 2375 · San Francisco, CA 94105
Tel: +1 (415) 371-8300 · Fax: +1 (415) 371-8311 · https://jaguar.health